Do cinnamon supplements cause acute hepatitis?

American Journal of Case Reports

Volumn 16, Issue , 2015, Pages 250-254

  Brancheau, Daniel ^a   Patel, Brijesh ^a   Zughaib, Marcel ^a  

^a PROVIDENCE HOSPITAL   (United States)

Author keywords

Cinnamomum aromaticum; Hepatitis; Hydroxymethylglutaryl CoA Reductase Inhibitors

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; CINNAMON EXTRACT; CLOPIDOGREL; INSULIN; LOSARTAN; METOPROLOL; PANTOPRAZOLE; PAROXETINE; ROSUVASTATIN;

ABDOMINAL PAIN; AGED; ARTICLE; BACKACHE; CASE REPORT; CHOLECYSTECTOMY; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENTING; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DIET SUPPLEMENTATION; DRUG MEGADOSE; DRUG UTILIZATION; DRUG WITHDRAWAL; FEMALE; GASTROESOPHAGEAL REFLUX; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYSTERECTOMY; LABORATORY TEST; LAPAROTOMY; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MEDICAL HISTORY; TOXIC HEPATITIS; VOMITING; ACUTE DISEASE; ADVERSE EFFECTS; CHEMICAL AND DRUG INDUCED LIVER INJURY; CINNAMOMUM ZEYLANICUM; DIETARY SUPPLEMENT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; X-RAY COMPUTED TOMOGRAPHY;

ACUTE DISEASE; AGED; CHEMICAL AND DRUG INDUCED LIVER INJURY; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CINNAMOMUM ZEYLANICUM; DIETARY SUPPLEMENTS; FEMALE; HUMANS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84929161513     PISSN: None     EISSN: 19415923     Source Type: Journal    
DOI: 10.12659/AJCR.892804     Document Type: Article

References (13)

1. Wang Z, Wang J, Chan P: Treating type 2 diabetes mellitus with traditional chinese and Indian medicinal herbs. Evid Based Complement Alternat Med, 2013; 2013: 343594
2. Yeh GY, Eisenberg DM, Kaptchuk TJ, Phillips RS: Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes. Diabetes Care, 2003; 26: 1277–94
3. Khan A, Safdar M, Ali Khan MM et al: Cinnamon Improves Glucose and Lipids of People With Type 2 Diabetes. Diabetes Care, 2003; 26: 3215–18
4. Ranasinghe P, Pigera S, Premakumara GA et al: Medicinal properties of ‘true’ cinnamon (Cinnamomum zeylanicum): a systematic review. BMC Complement Altern Med, 2013; 13: 275
5. Abraham K, Wohrlin F, Lindtner O et al: Toxicology and risk assessment of coumarin: focus on human data. Mol Nutr Food Res, 2010; 54: 228–39
6. Aragon G, Younossi ZM: When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Clev Clinic J Med, 2010; 77: 195–204
7. Green RM, Flamm S: AGA technical review on the evaluation of liver chemistry tests. Gastroenterology, 2002; 123: 1367–84
8. Famularo G, Miele L, Minisola G, Grieco A: Liver toxicity of rosuvastatin therapy. World J Gastroenterol, 2007; 13: 1286–88
9. Kashani A, Phillips CO, Foody JM et al: Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation, 2006; 114: 2788–97
10. Campbell AP: Diabetes and Dietary Supplements. Clinical Diabetes, 2010; 28: 35–39
11. Allen RW, Schwartzman E, Baker WL et al: Cinnamon Use in Type 2 Diabetes: An Updated Systematic Review and Meta-Analysis. Ann Fam Med, 2013; 11: 452–59
12. Ulbricht C, Seamon E, Windsor RC et al: An evidence-based systematic review of cinnamon (Cinnamomum spp.) by the Natural Standard Research Collaboration. J Diet Suppl, 2011; 8: 378–454
13. Naranjo CA, Busto U, Sellers EM et al: A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther, 1981; 30: 239–45